i2i, in collaboration with the Canadian Technology Accelerator (CTA), is set to host the final Demo Day of the year for the IP2 Launchpad Program on October 24 at the Nangang Software Park.
This event will focus on the medical and biotech industries, featuring 6 Canadian startups showcasing their innovative technologies and products.
Senior executives and mentors from the industry will be invited to attend, offering guidance and insights as the startups present their pitches.
see all startups 2024: https://www.startupterrace.com/2024-launchpad-teamlist
Startup Overview
A global medical technology company specializing in neuroimaging and precision intervention. Synaptive Medical aims to address clinical and workflow challenges in neurosurgery and modern operating rooms, advancing the field of precision medicine.
Provide surgeons with enhanced imaging and operational experiences, particularly for brain, spine, and tumor surgeries.
A leader in precision medicine and personalized healthcare, BioAro holds two approved patents and fourteen pending patents.
The company operates an advanced genomics lab and data analysis center, offering services such as whole genome sequencing (WGS), microbiome sequencing, and pharmacogenomics.
BioAro is also developing an AI-driven OMICS analysis platform and a blockchain-based data management system.
Focused on creating clinical decision support systems (CDSS) for Parkinson’s disease patients, with the founder being a Parkinson’s patient as well.
The company’s flagship product, the PRIMS system, uses 3D imaging and real-time data capture to assist clinicians in diagnosing and evaluating Parkinson’s disease more accurately and efficiently.
Specializing in wearable medical technology, VitalTracer has developed the "VT-Patch", a device designed for children to provide real-time health monitoring. It wirelessly tracks various vital signs, including blood oxygen levels, heart rate, respiratory rate, and skin temperature, and integrates an alert system.
Utilizing Gen AI to enhance predictive capabilities in clinical drug development, Simmunome accelerates the understanding of human biological responses to treatments, improving therapeutic efficiency and personalization.
Their flagship product is a SaaS-based multimodal disease modeling platform that integrates genomics, proteomics, and other data to simulate disease pathways.
Bowhead Health focuses on clinical decision support systems (CDSS) with a particular emphasis on precision medicine for clinical trial matching.
Their core product, the "Bowhead Navigator", is designed for oncology and offers precision matching of patients to clinical trials. The system analyzes patients' genomic data, medical history, and disease staging, reducing the matching process from days to minutes, while significantly improving accuracy.
This event promises to highlight cutting-edge solutions in healthcare technology, showcasing the potential of these startups to reshape the future of medical innovation.
Yorumlar